Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease

Clinical Infectious Diseases

Volumn 48, Issue 12, 2009, Pages

  Jang, Eun Young ^a   Park, Seong Yeon ^a   Lee, Eun Jung ^a   Song, Eun Hee ^a   Chong, Yong Pill ^a   Lee, Sang Oh ^a   Choi, Sang Ho ^a   Woo, Jun Hee ^a   Kim, Yang Soo ^a   Kim, Sung Han ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS ANTIGENEMIA ASSAY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS DIAGNOSIS;

ADULT; AGED; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 66949125047     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599116     Document Type: Article

References (12)

1. Mori T, Mori S, Kanda T, et al. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:431-4.
2. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992; 166:1223-7.
3. Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005; 50:609-16.
4. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996;88:4063-71.
5. Mori T, Okamoto S, Matsuoka S, et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25:765-9.
6. Kanda Y, Mineishi S, Saito T, et al. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoeitic stem cell transplantation: a single-center experience in Japan. Bone Marrow Transplantation 2001 ; 27:437-4.
7. Fica A, Cervera C, Pérez N, et al. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients:clinical features and usefulness ofconventional diagnostic tests. Transpl Infect Dis 2007; 9:203-10.
8. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalo- virus disease in liver transplant recipients. Transplantation 1999;68:1305-11.
9. Skiest DJ, Crosby C. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era. J Clin Virol 2003; 28:203-13.
10. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005;5: 218-27.
11. Muir SW, Murray J, Farquharson MA, Wheatley DJ, McPhaden AR. Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immu- nocytochemistry, in situ hybridisation, and nested PCR. J Clin Pathol 1998;51:807-11.
12. Boeckh M, Boivin G. Quantitaion of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998; 11:533-54.